Your account is not claimed yet. You can sign up with ORCID to claim your account.

Matthias A Karajannis (M A Karajannis, Matthias Karajannis)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 30

Top Venues

Neuro-oncology

Neuro-oncology advances

Pediatric blood & cancer

Nature communications

Weill Cornell Medical College

New York University School of Medicine (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Weill Cornell Medical College Jan 1o 2019

United States

Professor of Pediatrics :: Pediatrics

Education History

New York University School of Medicine

United States

MSC

Publications

Alexandra M Miller, Matthias A Karajannis
Cerebrospinal fluid: the new frontier for methylome-based diagnostic classification of brain tumors. Neuro-oncology (2023)
Daniel C Bowers, Veena Rajaram, Matthias A Karajannis, Sharon L Gardner, Jack Meng-Fen Su, Patricia Baxter, Sonia Partap, Laura J Klesse
Phase II study of everolimus for recurrent or progressive pediatric ependymoma. Neuro-oncology advances 5 (1) (2023)
Scott R Plotkin, Jeffrey Allen, Girish Dhall, Jian L Campian, D Wade Clapp, Michael J Fisher, Rakesh K Jain, James Tonsgard, Nicole J Ullrich, Coretta Thomas, Lloyd J Edwards, Bruce R Korf, Roger J Packer, Matthias A Karajannis, Jaishri O Blakely
Multicenter, prospective, phase 2 study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. Neuro-oncology (2023)
Sameer Farouk Sait, Alexandra M Giantini-Larsen, Kathryn R Tringale, Mark M Souweidane, Matthias A Karajannis
Treatment of Pediatric Low-Grade Gliomas. Current neurology and neuroscience reports (2023)
Sameer Farouk Sait, Cheryl Fischer, Zoltan Antal, Krisoula Spatz, Daniel E Prince, Katarzyna Ibanez, Gerald G Behr, Ira J Dunkel, Matthias A Karajannis
Slipped capital femoral epiphyses: A major on-target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patients. Pediatric blood & cancer (2023)
Maria Diaz, Satshil Rana, Carlos Eduardo Silva Correia, Anne S Reiner, Andrew L Lin, Alexandra M Miller, Maya S Graham, Sofia Chudsky, Tejus A Bale, Marc Rosenblum, Matthias A Karajannis, Elena Pentsova
Leptomeningeal disease in histone-mutant gliomas. Neuro-oncology advances 5 (1) (2023)
Anna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, Jonas Ecker, Florian Selt, Martin Mynarek, Denise Obrecht, Martin Sill, Robert J Autry, Eric Zhao, Steffen Hirsch, Elsa Amouyal, Christelle Dufour, Olivier Ayrault, Jacob Torrejon, Sebastian M Waszak, Vijay Ramsawami, Virve Pentikainen, Haci Ahmet Demir, Steven C Clifford, Ed C Schwalbe, Luca Massimi, Matija Snuderl, Kristyn Galbraith, Matthias A Karajannis, Katherine Hill, Bryan K Li, Mike Walsh, Christine L White, Shelagh Redmond, Loizou Loizos, Marcus Jakob, Uwe R Kordes, Irene Schmid, Julia Hauer, Claudia Blattmann, Maria Filippidou, Gianluca Piccolo, Wolfram Scheurlen, Ahmed Farrag, Kerstin Grund, Christian Sutter, Torsten Pietsch, Stephan Frank, Denis M Schewe, David Malkin, Myriam Ben-Arush, Astrid Sehested, Tai-Tong Wong, Kuo-Sheng Wu, Yen-Lin Liu, Fernando Carceller, Sabine Mueller, Schuyler Stoller, Michael D Taylor, Uri Tabori, Eric Bouffet, Marcel Kool, Felix Sahm, Andreas von Deimling, Andrey Korshunov, Katja von Hoff, Christian P Kratz, Dominik Sturm, David T W Jones, Stefan Rutkowski, Cornelis M van Tilburg, Olaf Witt, Gaëlle Bougeard, Kristian W Pajtler, Stefan M Pfister, Franck Bourdeaut, Till Milde
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome. Neuro-oncology (2023)
Sameer Farouk Sait, Alexandra M Giantini-Larsen, Kathryn R Tringale, Mark M Souweidane, Matthias A Karajannis
Treatment of Pediatric Low-Grade Gliomas. Current neurology and neuroscience reports (2023)
Kristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, Guomiao Shen, Ivy Tran, Nancy Abdallat, Mandisa Wen, Seema Patel, Misha Movahed-Ezazi, Arline Faustin, Marissa Spino-Keeton, Leah Geiser Roberts, Ekrem Maloku, Steven A Drexler, Benjamin L Liechty, David Pisapia, Olga Krasnozhen-Ratush, Marc Rosenblum, Seema Shroff, Daniel R Boué, Christian Davidson, Qinwen Mao, Mariko Suchi, Paula North, Amanda M Hopp, Annette Segura, Jason A Jarzembowski, Lauren Parsons, Mahlon D Johnson, Bret Mobley, Wesley Samore, Declan McGuone, Pallavi P Gopal, Peter D Canoll, Craig M Horbinski, Joseph M Fullmer, Midhat S Farooqui, Murat Gokden, Nitin R Wadhwani, Timothy E Richardson, Melissa Umphlett, Nadejda M Tsankova, John C DeWitt, Chandra Sen, Dimitris G Placantonakis, Donato Pacione, Jeffrey H Wisoff, Eveline Teresa Hidalgo, David Harter, Christopher M William, Christine Cordova, Sylvia C Kurz, Marissa Barbaro, Daniel A Orringer, Matthias A Karajannis, Erik P Sulman, Sharon L Gardner, David Zagzag, Aristotelis Tsirigos, Jeffrey C Allen, John G Golfinos, Matija Snuderl
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neuro-oncology advances 5 (1) (2023)
Anna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, Jonas Ecker, Florian Selt, Martin Mynarek, Denise Obrecht, Martin Sill, Robert J Autry, Eric Zhao, Steffen Hirsch, Elsa Amouyal, Christelle Dufour, Olivier Ayrault, Jacob Torrejon, Sebastian M Waszak, Vijay Ramsawami, Virve Pentikainen, Haci Ahmet Demir, Steven C Clifford, Ed C Schwalbe, Luca Massimi, Matija Snuderl, Kristyn Galbraith, Matthias A Karajannis, Katherine Hill, Bryan K Li, Mike Walsh, Christine L White, Shelagh Redmond, Loizou Loizos, Marcus Jakob, Uwe R Kordes, Irene Schmid, Julia Hauer, Claudia Blattmann, Maria Filippidou, Gianluca Piccolo, Wolfram Scheurlen, Ahmed Farrag, Kerstin Grund, Christian Sutter, Torsten Pietsch, Stephan Frank, Denis M Schewe, David Malkin, Myriam Ben-Arush, Astrid Sehested, Tai-Tong Wong, Kuo-Sheng Wu, Yen-Lin Liu, Fernando Carceller, Sabine Mueller, Schuyler Stoller, Michael D Taylor, Uri Tabori, Eric Bouffet, Marcel Kool, Felix Sahm, Andreas von Deimling, Andrey Korshunov, Katja von Hoff, Christian P Kratz, Dominik Sturm, David T W Jones, Stefan Rutkowski, Cornelis M van Tilburg, Olaf Witt, Gaëlle Bougeard, Kristian W Pajtler, Stefan M Pfister, Franck Bourdeaut, Till Milde
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome. Neuro-oncology (2023)
Daniel C Bowers, Veena Rajaram, Matthias A Karajannis, Sharon L Gardner, Jack Meng-Fen Su, Patricia Baxter, Sonia Partap, Laura J Klesse
Phase II study of everolimus for recurrent or progressive pediatric ependymoma. Neuro-oncology advances 5 (1) (2023)
Haley M Hardin, Christine T Dinh, Julianne Huegel, Alejandra M Petrilli, Olena Bracho, Abdulrahman Allaf, Matthias A Karajannis, Anthony J Griswold, Michael E Ivan, Jacques Morcos, Sakir H Gultekin, Fred F Telischi, Xue Zhong Liu, Cristina Fernandez-Valle
Co-targeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells. Molecular cancer therapeutics (2023)
N Shukla, Max Fine Levine, Gunes Gundem, D Domenico, B Spitzer, N Bouvier, J E Arango-Ossa, D Glodzik, J S Medina-Martínez, Umeshkumar K Bhanot, J Gutiérrez-Abril, Y Zhou, E Fiala, E Stockfisch, S Li, M I Rodriguez-Sanchez, T O'Donohue, Cassidy Cobbs, Michael H A Roehrl, Jamal K Benhamida, F Iglesias Cardenas, M Ortiz, M Kinnaman, S Roberts, M Ladanyi, S Modak, S Farouk-Sait, E Slotkin, Matthias A Karajannis, F Dela Cruz, Julia L Glade Bender, Ahmet Zehir, A Viale, Michael F Walsh, Andrew L Kung, Elli Papaemmanuil
Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. Nature communications 13 (1) (2022)
Alexandra M Miller, Luca Szalontay, Nancy Bouvier, Katherine Hill, Hamza Ahmad, Johnathan Rafailov, Alex J Lee, M Irene Rodriguez-Sanchez, Onur Yildirim, Arti Patel, Tejus A Bale, Jamal K Benhamida, Ryma Benayed, Maria E Arcila, Maria Donzelli, Ira J Dunkel, Stephen W Gilheeney, Yasmin Khakoo, Kim Kramer, Sameer F Sait, Jeffrey P Greenfield, Mark M Souweidane, Sofia Haque, Audrey Mauguen, Michael F Berger, Ingo K Mellinghoff, Matthias A Karajannis
Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients. Neuro-oncology 24 (10) (2022)
Tom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, Sanda Alexandrescu, Sanjay P Prabhu, Jessica W Tsai, Seth Malinowski, Mrinal Joshirao, Karishma Parikh, Sameer Farouk Sait, Marc K Rosenblum, Jamal K Benhamida, George Michaiel, Hung N Tran, Sonika M Dahiya, Kara Kachurak, Gregory K Friedman, Julie I Krystal, Michael A Huang, Ashley S Margol, Karen D Wright, Dolly Aguilera, Tobey J MacDonald, Susan N Chi, Matthias A Karajannis
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma. Neuro-oncology 24 (11) (2022)
Sameer Farouk Sait, Mauricio Rendon Bernot, Elizabeth Klein, David H Abramson, Jasmine H Francis, Stephen Gilheeney, Matthias A Karajannis, Barbara Spitzer, Suzanne L Wolden, Ira J Dunkel, Nancy A Kernan
Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma. Pediatric blood & cancer 70 (1) (2022)
Sameer Farouk Sait, Matthias A Karajannis
Chemotherapy plus focal radiation therapy for localized intracranial germinoma: How little is enough? Neuro-oncology 24 (6) (2022)
Matthias A Karajannis, Bryan K Li, Mark M Souweidane, Benjamin Liechty, JinJuan Yao, Jamal K Benhamida, Tejus A Bale, Marc K Rosenblum
YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma. Acta neuropathologica communications 10 (1) (2022)
Sameer Farouk Sait, Michael F Walsh, Matthias A Karajannis
Genetic syndromes predisposing to pediatric brain tumors. Neuro-oncology practice 8 (4) (2021)
Sameer Farouk Sait, Stephen W Gilheeney, Tejus A Bale, Sofia S Haque, Marc J Dinkin, Stephanie Vitolano, Marc K Rosenblum, Katarzyna Ibanez, Daniel E Prince, Krisoula H Spatz, Ira J Dunkel, Matthias A Karajannis
Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas. JCO precision oncology 5 (2021)
Matthias A Karajannis, Audrey Mauguen, Ekrem Maloku, Qingwen Xu, Erin M Dunbar, Scott R Plotkin, Anna Yaffee, Shiyang Wang, J Thomas Roland, Chandranath Sen, Dimitris G Placantonakis, John G Golfinos, Jeffrey C Allen, Nicholas A Vitanza, Luis A Chiriboga, Robert J Schneider, Jingjing Deng, Thomas A Neubert, Judith D Goldberg, David Zagzag, Filippo G Giancotti, Jaishri O Blakely
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma. Molecular cancer therapeutics 20 (9) (2021)
Sameer Farouk Sait, Matthias A Karajannis
Pediatric spinal cord gliomas-low grade but high risk for recurrence: should we treat them differently from intracranial low-grade gliomas? Neuro-oncology 23 (7) (2021)
Mariko D DeWire, Christine Fuller, Olivia Campagne, Tong Lin, Haitao Pan, T Young Poussaint, Patricia A Baxter, Eugene I Hwang, Andrew Bukowinski, Kathleen Dorris, Lindsey Hoffman, Angela J Waanders, Matthias A Karajannis, Clinton F Stewart, Arzu Onar-Thomas, Maryam Fouladi, Ira J Dunkel
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Karen D Wright, Xiaopan Yao, Wendy B London, Pei-Chi Kao, Lia Gore, Stephen Hunger, Russ Geyer, Kenneth J Cohen, Jeffrey C Allen, Howard M Katzenstein, Amy Smith, Jessica Boklan, Kellie Nazemi, Tanya Trippett, Matthias A Karajannis, Cynthia Herzog, Joseph Destefano, Jennifer Direnzo, Jay Pietrantonio, Lianne Greenspan, Danielle Cassidy, Debra Schissel, John Perentesis, Mitali Basu, Tomoyuki Mizuno, Alexander A Vinks, Sanjay P Prabhu, Susan N Chi, Mark W Kieran
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatric blood & cancer 68 (2) (2020)
Matthew Clarke, Alan Mackay, Britta Ismer, Jessica C Pickles, Ruth G Tatevossian, Scott Newman, Tejus A Bale, Iris Stoler, Elisa Izquierdo, Sara Temelso, Diana M Carvalho, Valeria Molinari, Anna Burford, Louise Howell, Alex Virasami, Amy R Fairchild, Aimee Avery, Jane Chalker, Mark Kristiansen, Kelly Haupfear, James D Dalton, Wilda Orisme, Ji Wen, Michael Hubank, Kathreena M Kurian, Catherine Rowe, Mellissa Maybury, Stephen Crosier, Jeffrey Knipstein, Ulrich Schüller, Uwe Kordes, David E Kram, Matija Snuderl, Leslie Bridges, Andrew J Martin, Lawrence J Doey, Safa Al-Sarraj, Christopher Chandler, Bassel Zebian, Claire Cairns, Rachael Natrajan, Jessica K R Boult, Simon P Robinson, Martin Sill, Ira J Dunkel, Stephen W Gilheeney, Marc K Rosenblum, Debbie Hughes, Paula Z Proszek, Tobey J Macdonald, Matthias Preusser, Christine Haberler, Irene Slavc, Roger Packer, Ho-Keung Ng, Shani Caspi, Mara Popović, Barbara Faganel Kotnik, Matthew D Wood, Lissa Baird, Monika Ashok Davare, David A Solomon, Thale Kristin Olsen, Petter Brandal, Michael Farrell, Jane B Cryan, Michael Capra, Michael Karremann, Cornelia Brendle, Martin U Schuhmann, Martin Ebinger, Winand N M Dinjens, Kornelius Kerl, Simone Hettmer, Torsten Pietsch, Felipe Andreiuolo, Pablo Hernáiz Driever, Andrey Korshunov, Lotte Hiddingh, Barbara C Worst, Dominik Sturm, Marc Zuckermann, Olaf Witt, Tabitha Bloom, Clare Mitchell, Evelina Miele, Giovanna Stefania Colafati, Francesca Diomedi-Camassei, Simon Bailey, Andrew S Moore, Timothy E G Hassall, Stephen P Lowis, Maria Tsoli, Mark J Cowley, David S Ziegler, Matthias A Karajannis, Kristian Aquilina, Darren R Hargrave, Fernando Carceller, Lynley V Marshall, Andreas von Deimling, Christof Maria Kramm, Stefan M Pfister, Felix Sahm, Suzanne J Baker, Angela Mastronuzzi, Andrea Carai, Maria Vinci, David Capper, Sergey Popov, David W Ellison, Thomas S Jacques, David T W Jones, Chris Jones
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes. Cancer discovery 10 (7) (2020)
Matthias A Karajannis, Mark M Souweidane, Ira J Dunkel
Letter to the Editor regarding clinical debate concerning treatment of pediatric LGG by Cooney et al. Neuro-oncology practice 7 (5) (2020)
Matija Snuderl, Igor Dolgalev, Adriana Heguy, Michael F Walsh, Ryma Benayed, Achim A Jungbluth, Marc Ladanyi, Matthias A Karajannis
Histone H3K36I mutation in a metastatic histiocytic tumor of the skull and response to sarcoma chemotherapy. Cold Spring Harbor molecular case studies 5 (5) (2019)
James M Stafford, Chul-Hwan Lee, Philipp Voigt, Nicolas Descostes, Ricardo Saldaña-Meyer, Jia-Ray Yu, Gary Leroy, Ozgur Oksuz, Jessica R Chapman, Fernando Suarez, Aram S Modrek, N Sumru Bayin, Dimitris G Placantonakis, Matthias A Karajannis, Matija Snuderl, Beatrix Ueberheide, Danny Reinberg
Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma. Science advances 4 (10) (2018)
Matija Snuderl, Kasthuri Kannan, Elke Pfaff, Shiyang Wang, James M Stafford, Jonathan Serrano, Adriana Heguy, Karina Ray, Arline Faustin, Olga Aminova, Igor Dolgalev, Stacie L Stapleton, David Zagzag, Luis A Chiriboga, Sharon L Gardner, Jeffrey H Wisoff, John G Golfinos, David Capper, Volker Hovestadt, Marc K Rosenblum, Dimitris G Placantonakis, Sarah E LeBoeuf, Thales Y Papagiannakopoulos, Lukas Chavez, Sama Ahsan, Charles G Eberhart, Stefan M Pfister, David T W Jones, Matthias A Karajannis
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma. Nature communications 9 (1) (2018)
Seema Patel, Shiyang Wang, Matija Snuderl, Matthias A Karajannis
Pre-treatment lymphopenia and indication of tumor-induced systemic immunosuppression in medulloblastoma. Journal of neuro-oncology 136 (3) (2017)

Matthias A Karajannis.css-eqlu8i{font-size:small;padding-left:4px;} (M A Karajannis, Matthias Karajannis)

Publication Activity (10 Years)

Top Topics

Top Venues

Matthias A Karajannis (M A Karajannis, Matthias Karajannis)